Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Ramiro

Showing results (131-140 of 287) with videos related to

Pageof 29
Sort By:
Annals of the Rheumatic Diseases|December 10, 2017
Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA studyElena Nikiphorou, Désirée van der Heijde, Sam Norton, et al.
Acta Reumatologica Portuguesa|June 24, 2020
The European Portuguese version of the ASAS Health Index for Patients with Spondyloarthritis: Measurement propertiesSantiago Rodrigues-Manica, Eduardo Cruz, Sofia Ramiro, et al.
RMD Open|February 9, 2017
Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritisAndrea Regel, Alexandre Sepriano, Xenofon Baraliakos, et al.
Rheumatology (Oxford, England)|September 13, 2022
Treating spondyloarthritis early: does it matter? Results from a systematic literature reviewDafne Capelusnik, Diego Benavent, Désirée van der Heijde, et al.
Seminars in Arthritis and Rheumatism|June 1, 2023
Bone marrow edema in the sacroiliac joints is associated with the development of structural lesions at the same anatomical location over time in patients with axial spondyloarthritisSantiago Rodrigues-Manica, Alexandre Sepriano, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|March 26, 2016
Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARDPolina Putrik, Sofia Ramiro, Elisabeth Lie, et al.
Acta Reumatologica Portuguesa|November 26, 2011
Biologicals and switch in rheumatoid arthritis throughout time - are we being more aggressive?Sofia Ramiro, Raquel Roque, Filipe Vinagre, et al.
RMD Open|June 26, 2021
Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohortElena Nikiphorou, Pedro D Carvalho, Annelies Boonen, et al.
Annals of the Rheumatic Diseases|October 21, 2022
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritisCasper Webers, Augusta Ortolan, Alexandre Sepriano, et al.
RMD Open|May 13, 2020
5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohortQueeny Madari, Alexandre Sepriano, Sofia Ramiro, et al.
Pageof 29

Showing results (131-140 of 287) with videos related to

Sort By:
Pageof 29
Annals of the Rheumatic Diseases|December 10, 2017
Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA studyElena Nikiphorou, Désirée van der Heijde, Sam Norton, et al.
Acta Reumatologica Portuguesa|June 24, 2020
The European Portuguese version of the ASAS Health Index for Patients with Spondyloarthritis: Measurement propertiesSantiago Rodrigues-Manica, Eduardo Cruz, Sofia Ramiro, et al.
RMD Open|February 9, 2017
Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritisAndrea Regel, Alexandre Sepriano, Xenofon Baraliakos, et al.
Rheumatology (Oxford, England)|September 13, 2022
Treating spondyloarthritis early: does it matter? Results from a systematic literature reviewDafne Capelusnik, Diego Benavent, Désirée van der Heijde, et al.
Seminars in Arthritis and Rheumatism|June 1, 2023
Bone marrow edema in the sacroiliac joints is associated with the development of structural lesions at the same anatomical location over time in patients with axial spondyloarthritisSantiago Rodrigues-Manica, Alexandre Sepriano, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|March 26, 2016
Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARDPolina Putrik, Sofia Ramiro, Elisabeth Lie, et al.
Acta Reumatologica Portuguesa|November 26, 2011
Biologicals and switch in rheumatoid arthritis throughout time - are we being more aggressive?Sofia Ramiro, Raquel Roque, Filipe Vinagre, et al.
RMD Open|June 26, 2021
Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohortElena Nikiphorou, Pedro D Carvalho, Annelies Boonen, et al.
Annals of the Rheumatic Diseases|October 21, 2022
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritisCasper Webers, Augusta Ortolan, Alexandre Sepriano, et al.
RMD Open|May 13, 2020
5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohortQueeny Madari, Alexandre Sepriano, Sofia Ramiro, et al.
Pageof 29